12-53321423-G-A
Variant summary
Our verdict is Pathogenic. The variant received 18 ACMG points: 18P and 0B. PVS1PM2PP5_Very_Strong
The NM_015665.6(AAAS):c.43C>T(p.Gln15*) variant causes a stop gained change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00000124 in 1,614,112 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a pathogenic outcome for this variant. Variant has been reported in ClinVar as Pathogenic (★★). Synonymous variant affecting the same amino acid position (i.e. Q15Q) has been classified as Likely benign.
Frequency
Consequence
NM_015665.6 stop_gained
Scores
Clinical Significance
Conservation
Publications
- triple-A syndromeInheritance: AR Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: G2P, Ambry Genetics, Labcorp Genetics (formerly Invitae), Orphanet
Genome browser will be placed here
ACMG classification
Our verdict: Pathogenic. The variant received 18 ACMG points.
Variant Effect in Transcripts
ACMG analysis was done for transcript: NM_015665.6. You can select a different transcript below to see updated ACMG assignments.
RefSeq Transcripts
| Selected | Gene | Transcript | Tags | HGVSc | HGVSp | Effect | Exon Rank | Protein | UniProt |
|---|---|---|---|---|---|---|---|---|---|
| AAAS | NM_015665.6 | MANE Select | c.43C>T | p.Gln15* | stop_gained | Exon 1 of 16 | NP_056480.1 | ||
| AAAS | NM_001173466.2 | c.43C>T | p.Gln15* | stop_gained | Exon 1 of 15 | NP_001166937.1 |
Ensembl Transcripts
| Selected | Gene | Transcript | Tags | HGVSc | HGVSp | Effect | Exon Rank | Protein | UniProt |
|---|---|---|---|---|---|---|---|---|---|
| AAAS | ENST00000209873.9 | TSL:1 MANE Select | c.43C>T | p.Gln15* | stop_gained | Exon 1 of 16 | ENSP00000209873.4 | ||
| AAAS | ENST00000394384.7 | TSL:1 | c.43C>T | p.Gln15* | stop_gained | Exon 1 of 15 | ENSP00000377908.3 | ||
| AAAS | ENST00000546393.7 | TSL:5 | n.141C>T | non_coding_transcript_exon | Exon 1 of 8 |
Frequencies
GnomAD3 genomes AF: 0.00000657 AC: 1AN: 152256Hom.: 0 Cov.: 32 show subpopulations
GnomAD2 exomes AF: 0.00000398 AC: 1AN: 251366 AF XY: 0.00000736 show subpopulations
GnomAD4 exome AF: 6.84e-7 AC: 1AN: 1461856Hom.: 0 Cov.: 31 AF XY: 0.00000138 AC XY: 1AN XY: 727220 show subpopulations ⚠️ The allele balance in gnomAD version 4 Exomes is significantly skewed from the expected value of 0.5.
Age Distribution
GnomAD4 genome AF: 0.00000657 AC: 1AN: 152256Hom.: 0 Cov.: 32 AF XY: 0.0000134 AC XY: 1AN XY: 74390 show subpopulations
Age Distribution
ClinVar
Submissions by phenotype
not provided Pathogenic:2
PM2_moderate, PM3, PVS1
This sequence change creates a premature translational stop signal (p.Gln15*) in the AAAS gene. It is expected to result in an absent or disrupted protein product. Loss-of-function variants in AAAS are known to be pathogenic (PMID: 11159947). This variant is present in population databases (no rsID available, gnomAD 0.003%). This variant has not been reported in the literature in individuals affected with AAAS-related conditions. Algorithms developed to predict the effect of sequence changes on RNA splicing suggest that this variant may create or strengthen a splice site. For these reasons, this variant has been classified as Pathogenic.
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at